Jefferies analyst Stephen Barker downgraded PeptiDream to Hold from Buy with a price target of 1,900 yen, down from 2,200 yen. The analyst has become more optimistic about the company’s radiopharma revenues, but less optimistic about margins.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PPTDF: